The Zephyr-7B model has been trained using a three-step strategy. The first step involves distilled supervised fine-tuning using the Ultra Chat dataset. This dataset, comprising 1.47 million ...
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision medicine in cancer drug ...
Pharmaceutical Technology on MSN
Guardant and Zephyr AI pair up to advance cancer biomarker development
According to the companies, pairing Guardant multimodal real-world data and precision oncology insights with Zephyr’s proprietary AI technologies will accelerate research and de ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Stability AI is perhaps best known for its ...
Data-driven startup Zephyr AI has raised $18.5 million in seed funding to advance precision medicine and drug discovery with machine learning. The startup’s tech combines data from multiple sources, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback